Immatics Highlights Compelling Anti-Tumor Activity of Anzu-cel PRAME Cell Therapy in Metastatic Uveal Melanoma at the ESMO 2025 Presidential Symposium
Immatics Highlights Compelling Anti-Tumor Activity of Anzu-cel P…
4 months ago
finanznachrichten.de
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 A…
9 months ago
finanznachrichten.de
Immatics Presents Clinical Proof-of-Concept Data from Ongoing Phase 1 Dose Escalation Trial with TCR Bispecific Molecule TCER IMA401 Targeting MAGEA4/8 at ESMO 2024 and Provides Development Update
Immatics Presents Clinical Proof-of-Concept Data from Ongoing Phas…
Sep 16, 2024
finanznachrichten.de
Immatics’ Clinical ACTengine® TCR-T Trials: A Patient’s Journey
Immatics’ Clinical ACTengine® TCR-T Trials: A Patient’s Journey
1.7K viewsApr 27, 2022
YouTubeImmatics
Immatics Therapeutic Approach
5:18
Immatics Therapeutic Approach
5.9K viewsAug 20, 2020
YouTubeImmatics
Immatics’ Clinical TCR Bispecifics (TCER®) Trials: A Patient’s Journey
3:19
Immatics’ Clinical TCR Bispecifics (TCER®) Trials: A Patient’s Journey
1.2K viewsJul 5, 2022
YouTubeImmatics
15 reactions | Proud to see the MACSQuant® Tyto® Cell Sorter is...
0:11
15 reactions | Proud to see the MACSQuant® Tyto® Cell Sorter is...
258 views2 weeks ago
FacebookMiltenyi Biotec
Immatics N.V. publie des données actualisées sur l'escalade de dos…
3 months ago
zonebourse.com
Immatics shares early data on bispecific antibodies in Phase 1 tri…
3 months ago
linkedin.com
Immatics Announces Upcoming Oral Presentation at the Society fo…
Oct 11, 2024
finanznachrichten.de
10:01
Hoffnungsträger (1) - immatics biotechnologies
Aug 27, 2014
n-tv.den-tv NACHRICHTEN
1:04:03
Harpreet Singh, Immatics 🇩🇪 | PRAME, TCR Based Therapeutics | E20
1.2K viewsSep 2, 2024
YouTubeFlotBio x Philip Hemme
#cell2025 #lifescience #biotech #nextgenbiomed #celltherapy | Im…
3 months ago
linkedin.com
#cancer #immunotherapy #sitc #immunooncology #immunology …
Oct 4, 2024
linkedin.com
BofA Adjusts Price Target on Immatics to $17 From $14, Maintai…
1 month ago
marketscreener.com
Immatics appoints Venkat Ramanan as chief financial officer
4 months ago
marketscreener.com
1:01
Immatics on Instagram: "Today, we announced updated Phase 1a dos…
365 views3 months ago
Instagramimmatics
0:47
RTF.1-Nachrichten: Immatics und MorphoSys im Kampf gegen Krebs
77 viewsAug 26, 2015
YouTubeKlarnerMedien
News for IMTX
2 months ago
zacks.com
Oncology | GSK
Jun 10, 2022
gsk.com
7277633399001468166
Sep 17, 2023
TikTok
1:01:05
A-Cell: Generation of QTPP, Risk Assessment and Critical Quality A…
3.8K viewsOct 26, 2022
YouTubeAlliance for Regenerative Medicine
20:01
Building a Voice Agent for Kids (Part 1/3): Audio-to-Text Transcrip…
4 views3 months ago
YouTubeImantix AI Academy
53:57
Manufacturing of endogenous, non-engineered, antigen - specific T ce…
448 viewsAug 21, 2020
YouTubeMiltenyi Biotec
XING
Jan 29, 2021
xing.com
55:59
ESMO 2025 Highlights: Key Uveal Melanoma Trial Updates with Dr. H…
1 month ago
YouTubeA Cure In Sight Ocular Melanoma
50:23
Understanding the Impact of MFN & Tariffs on the Cell & Gene Therap…
28 views1 month ago
YouTubeAlliance for Regenerative Medicine
0:14
Immatics N.V. Stock Price 5 Years Timelaps 📈 #stocks
9 views2 months ago
YouTubeMissedTheBus?
58:52
Stephane Bancel, Moderna | mRNA Therapeutics, Boston Biotech Mafi…
1.8K views8 months ago
YouTubeFlotBio x Philip Hemme
See more videos
Static thumbnail place holder